Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jess R Hoag

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Oncologist|June 17, 2024
Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancerMadappa N Kundranda, Ariane C Kemkes, Mark C Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast CancerLajos Pusztai, Jess R Hoag, Kathy S Albain, et al.
Oncotarget|July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumorsJean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Journal of Medical Economics|March 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumorsJesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Oncologist|June 17, 2024
Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancerMadappa N Kundranda, Ariane C Kemkes, Mark C Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast CancerLajos Pusztai, Jess R Hoag, Kathy S Albain, et al.
Oncotarget|July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumorsJean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Journal of Medical Economics|March 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumorsJesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema, et al.
Pageof 1